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 Abstract 
 Background. As arteries become stiffer with ageing, refl ected waves move faster and augment late systolic pressure. We 
investigated the age dependency of peripheral and central systolic pressure, pressure amplifi cation (peripheral systolic blood 
pressure   central systolic blood pressure), and peripheral and central systolic augmentation (maximal systolic pressure 
minus the fi rst peak of the pressure wave).  Methods. We randomly recruited 1420 White Europeans (mean age, 41.7 years). 
peripheral systolic blood pressure and central systolic blood pressure were measured by means of an oscillometric sphyg-
momanometer and pulse wave analysis, respectively.  Results. In cross-sectional analyses (731 women, 689 men), central 
systolic blood pressure and central systolic augmentation increased more with age than peripheral systolic blood pressure 
and peripheral systolic augmentation. These age-related increases were greater in women than men. The age-related decrease 
in pressure amplifi cation was similar in both sexes. In longitudinal analyses (208 women, 190 men), the annual increases 
in central systolic blood pressure and central systolic augmentation were steeper ( p   0.001) than those in peripheral systo-
lic blood pressure and peripheral systolic augmentation with no sex differences ( p   0.068), except for peripheral systolic 
augmentation, which was larger in women ( p   0.002). Longitudinally, pressure amplifi cation decreased more with age in 
women than men ( p   0.012). In multivariable-adjusted analyses, age was the overriding determinant of peripheral systolic 
blood pressure and central systolic blood pressure.  Conclusion. With ageing, peripheral systolic blood pressure approximates 
to central systolic blood pressure. This might explain why in older subjects peripheral systolic blood pressure becomes the 
main predictor of cardiovascular complications. 
 Key Words:  ageing ,  cardiovascular disease ,  central blood pressure ,  epidemiology ,  peripheral blood pressure ,  risk factors 
 Introduction 
 Systolic blood pressure substantially rises with age-
ing across the full human life span (1). However, 
because arteries stiffen with higher age and because 
of differences in wave travel distance and wave 
refl ections, the age-related increase in systolic blood 
pressure does not occur uniformly across the whole 
arterial tree (2). Indeed, during systole, the heart 
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generates a forward running pressure wave, which is 
refl ected at various sites in the peripheral arterial sys-
tem (2). In healthy young adults, the refl ected waves 
coincide with diastole and raise diastolic pressure. As 
the arteries become stiffer with advancing age, the 
refl ected waves move faster, reach the proximal aorta 
during systole and cause an augmentation of late sys-
tolic pressure, whereas diastolic pressure decreases. 
 Augmentation of systolic blood pressure in the 
central arteries increases with advancing age. Because 
of this phenomenon, there might be differences in the 
age dependency of peripheral systolic blood pressure, 
as measured at the brachial artery, and central systolic 
blood pressure, as estimated non-invasively by pulse 
wave analysis. We previously reported reference values 
for the central and peripheral pulse pressures and aug-
mentation indexes by age in healthy Europeans (3). 
In the present study, we focused on the changes with 
age in central and peripheral systolic blood pressures, 
systolic amplifi cation, and the difference between the 
augmented and non-augmented systolic blood pres-
sures. In randomly recruited European subjects, we 
assessed these age-related changes cross-sectionally 
and in a subsample also longitudinally. We excluded 
patients on antihypertensive drug treatment from 
all analyses to avoid confounding by blood pressure 
lowering medications. 
 Methods 
 Study population 
 Recruitment for the Flemish Study on Environment, 
Genes and Health Outcomes (FLEMENGHO) 
started in 1985 (4,5). From August 1985 until 
November 1990, a random sample of the households 
living in a geographically defi ned area of Northern 
Belgium was investigated with the goal to recruit an 
equal number of participants in each of six subgroups 
by sex and age (20 – 39, 40 – 59 and   60 years). All 
household members with a minimum age of 20 years 
were invited to take part, provided the quota of their 
sex-age group had not yet been fulfi lled. From June 
1996 until January 2004, recruitment of families 
continued using the former participants (1985   1990) 
as index persons and also including subjects younger 
than 20 years. The subjects were repeatedly followed 
up. In all study phases, i.e. at baseline and at fol-
low-up, we employed the same standardized meth-
ods to measure peripheral and central blood pressure, 
laboratory tests and administer questionnaires. 
 The European Project on Genes in Hypertension 
(EPOGH) started in 1998 (6,7). The EPOGH inves-
tigators were trained at the Studies Coordinating 
Centre in Leuven, Belgium, and applied the same 
protocol, questionnaires and follow-up procedures, 
as used in FLEMENGHO. Questionnaires were 
translated from Dutch into Czech, Italian and Polish, 
and back-translated into Dutch to check that all 
questions had the same meaning in all languages. 
FLEMENGHO and EPOGH were conducted 
according to the principles outlined in the Helsinki 
Declaration for Investigation of Human Subjects (8). 
Each local Institutional Review Board approved the 
study protocol. Participants gave informed consent 
in writing. 
 As shown in Figure 1, 949 FLEMENGHO and 
858 EPOGH participants had their blood pressure 
Figure 1. Flow chart of study participants.
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60 W. Wojciechowska et al.
measured and their pulse wave analysed at baseline. 
Of 1807 participants with arterial measurements 
available, we excluded 387 on antihypertensive drug 
treatment, leaving 1420 subjects, 731 women and 
689 men, for the cross-sectional analysis of baseline 
data. Of 1420 subjects included in the baseline anal-
ysis, three died, one was severely ill and 225 moved 
out of the study areas, and were therefore unavailable 
for the scheduled follow-up examination. Of the 
remaining 1191 subjects, 743 did not participate in 
the follow-up study because they are currently still 
proceeding to follow-up. We excluded from analysis 
an additional 50 subjects on antihypertensive drug 
treatment at follow-up. The number of subjects 
available for the longitudinal analyses totalled 
398 (208 women and 190 men). 
 Measurement of peripheral and central 
blood pressure 
 The fi rst phase of arterial phenotyping (baseline) 
took place from March 2002 until June 2009 in 
FLEMENGHO and from October 2000 until 
February 2008 in EPOGH. Arterial phenotyping at 
follow-up was done from February 2006 until June 
2010 in FLEMENGHO and from January 2006 
until July 2007 in the EPOGH centres. 
 To ensure steady state, measurements of peri-
pheral and central blood pressures were obtained at 
local examination centres after the subjects had 
rested for at least 15 min in the supine position and 
had refrained from smoking, heavy exercise, and 
drinking alcohol or caffeinated beverages for at least 
2 h prior to the examination. Brachial (peripheral) 
blood pressure was the average of three consecutive 
readings obtained by the validated (9) OMRON 
705CP oscillometric sphygmomanometer (Omron 
Inc., Kyoto, Japan). For subjects with an arm circum-
ference of less than 32 cm, a standard cuff with an 
infl atable bladder of 22   12 cm was used. For par-
ticipants with a greater arm circumference, cuffs with 
a 35   15 cm bladder were used. Hypertension was 
a blood pressure of at least 140 mmHg systolic or 
90 mmHg diastolic. 
 Trained observers did the arterial measurements. 
During an 8-second period, they recorded the radial 
arterial waveform at the dominant arm by applana-
tion tonometry. They used a high-fi delity SPC-301 
micromanometer (Millar Instruments, Inc., Hous-
ton, TX, USA) interfaced with a laptop computer 
running the SphygmoCor software (AtCor Medical 
Pty. Ltd., West Ryde, New South Wales, Australia), 
version 6.31 at baseline and version 7.1 at follow-up. 
Recordings were discarded when the systolic or dia-
stolic variability of consecutive waveforms exceeded 
5% or when the amplitude of the pulse wave signal 
was less than 80 mV. The radial pulse wave was cal-
ibrated by the supine brachial blood pressure mea-
sured at the same arm, which as described above was 
measured immediately before the tonometric record-
ings. From the radial signal, the SphygmoCor soft-
ware calculates the aortic pulse wave by means of a 
validated (10,11) generalized transfer function. The 
software returns the central systolic blood pressure 
and the pressure at the fi rst (P1) and second (P2) peak 
or shoulder of the central and radial waveforms. 
 In each country, the observers involved in the 
study took part in a reproducibility study of the 
SphygmoCor measurements. After repeat examina-
tion of 10 – 12 subjects, we computed the coeffi cient 
of variation as the ratio of the mean difference 
between repeat measurements to the standard devia-
tion of the paired differences multiplied by 100 (12). 
Intra-observer and inter-observer variability were 
around 3% and 5%, respectively (3). 
 For the present analysis, peripheral systolic blood 
pressure was the average of the three blood pressure 
readings obtained at the brachial artery for calibra-
tion of the pressure waves. Central systolic blood 
pressure was the maximum pressure of the central 
waveform. We calculated systolic augmentation by 
subtracting P1 from systolic blood pressure. Pressure 
amplifi cation was defi ned as peripheral minus central 
systolic blood pressure. 
 Other measurements 
 We administered a standardized questionnaire to 
obtain information on each subject ’ s medical history, 
smoking and drinking habits, and use of medications. 
Venous blood was collected after overnight fasting. 
We measured total serum cholesterol and blood glu-
cose by automated enzymatic methods. Body mass 
index was body weight in kilograms divided by height 
in meters squared. Diabetes mellitus was defi ned as 
a fasting blood glucose concentration of at least 7.0 
mmol/l (126 mg/dl) or the use of antidiabetic drugs. 
 Statistical methods 
 For database management and statistical analysis, we 
used SAS software, version 9.1.3 (SAS Institute, 
Cary, NC, USA). For comparison of means and pro-
portions, we applied the large-sample  z -test or  t -test 
for paired observations and the  χ 2 statistic, respec-
tively. For assessment of the cross-sectional associa-
tion between blood pressure and age, we applied the 
PROC MIXED procedure, as implemented in the SAS 
software to account for family clusters. In the longi-
tudinal analyses, we determined the signifi cance of 
pressure amplifi cation, systolic augmentation pres-
sure and the longitudinal trends in the measurements 
by dividing the group mean differences or changes 
by the corresponding standard error (SE). In the last 
step of our analyses, we searched for variables associ-
ated with the peripheral and central blood pressure 
measurements, using stepwise linear regression. We 
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set the  p -values for variables to enter and to stay in 
the regression models at 0.05. We tested the null 
hypothesis of no differences between the regression 
slopes of haemodynamic measurements on age, using 
multivariable analysis of variance as implemented in 
the MTEST statement of the PROC REG procedure 
of the SAS package (13). In all analyses, statistical 
signifi cance was a  p -value of 0.05 or less on two-
sided tests. 
 Results 
 Characteristics of participants 
 The 1420 participants included 731 women (51.5%) 
and 278 (19.6%) hypertensive patients, of whom by 
design of the analysis, none was taking antihyperten-
sive drugs. Age ranged from 12 – 89 years. Table I 
gives the anthropometric characteristics, risk factors, 
and the peripheral and central haemodynamic mea-
surements for women and men separately. Among all 
participants, fewer women than men smoked (18.9% 
vs 29.7%;  p   0.0001) or reported regular alcohol 
consumption (41.0% vs 71.7%;  p   0.0001). Periph-
eral systolic, diastolic and pulse pressures were sig-
nifi cantly lower in women than men ( p   0.0001). 
Similarly, central systolic and diastolic blood pressures 
( p   0.0001), but not pulse pressure ( p   0.82), were 
lower in women. 
 Of 731 women and 689 men, 208 (28.4%) and 
190 (27.6%), respectively, underwent a repeat exa-
mination at a median interval of 4.79 years (5th to 
95th percentile interval, 3.96 – 5.98 years). Table I 
also provides the baseline characteristics of this sub-
sample by sex. The characteristics of the subsample 
were similar to those of the whole study group. 
 Associations of peripheral and central systolic 
blood pressures with age 
 In cross-sectional analyses of 731 women and 689 men, 
the peripheral and central systolic blood pressures 
increased with age ( p for trend   0.01; Figure 2, 
Panels A and B). In single regression analysis, the 
cross-sectionally assessed age-related increase in cen-
tral systolic blood pressure was larger than that in 
peripheral systolic pressure (Table II) both in women 
(0.73 vs 0.48 mmHg/year;  p   0.0001) and in men 
(0.51 vs 0.27 mmHg/year;  p   0.0001). The slopes of 
peripheral and central systolic blood pressures on age 
were steeper ( p   0.001) in women than in men. The 
amplifi cation pressure, the difference between peri-
pheral and central systolic pressure decreased 
with age at a rate of   0.24 mmHg/year in both sexes 
 Table I. Baseline characteristics of participants by study phase and sex. 
All participants Participants with follow-up
Characteristic Women Men Women Men
Number 731 689 208 190
 Noorderkempen 374 (51.2) 352 (51.1) 102 (49.0) 95 (50.0)
 Pilsen 73 (10.0) 73 (10.6) 43 (20.7) 27 (14.2)
 Padova 119 (16.3) 120 (17.4)  –  – 
 Krak ó w 165 (22.6) 144 (20.1) 63 (30.3) 68 (35.8)
Anthropometrics
 Age, year 41.4  	 15.0 42.0  	 15.7 40.1  	 14.3 39.2  	 15.7
 Height, cm 163.4  	 6.5 176.0  	 7.1 ‡ 164.4  	 6.9 176.8  	 7.2 ‡ 
 Weight, kg 66.0  	 12.8 80.3  	 12.9 ‡ 65.8  	 12.6 71.2  	 12.1 ‡ 
 Body mass index, kg/m 2 24.9  	 4.6 25.9  	 4.1 ‡ 24.3  	 4.3 25.3  	 3.5 ∗ 
Risk factors
 Current smoking,  n (%) 138 (18.9) 205 (29.7) ‡ 43 (20.7) 63 (33.2) † 
 Alcohol intake,  n (%) 300 (41.0) 494 (71.7)‡ 59 (28.4) 105 (55.3) ‡ 
 Total cholesterol, mmol/l 5.05  	 1.05 5.04  	 1.05 5.13  	 1.10 5.13  	 1.15
 Blood glucose, mmol/l 4.90  	 0.83 5.17  	 1.20 ‡ 4.84  	 0.38 5.20  	 0.47 ∗ 
 Hypertension, n (%) 104 (14.2) 174 (25.3) ‡ 21 (10.1) 35 (18.4) ∗ 
 Diabetes, n (%) 17 (2.33) 34 (4.93) † 0 0
 Previous CVD, n (%) 44 (6.02) 58 (8.42) 10 (4.81) 18 (9.49)
Peripheral haemodynamics
 Systolic pressure, mmHg 120.4  	 16.1 127.6  	 14.9 ‡ 117.9  	 15.6 124.6  	 12.6 ‡ 
 Diastolic pressure, mmHg 75.1  	 10.2 78.9  	 10.6 ‡ 73.8  	 9.7 76.8  	 10.3 ‡ 
 Pulse pressure, mmHg 45.3  	 11.3 48.7  	 11.7‡ 44.1  	 10.5 47.7  	 10.6 ‡ 
 Heart rate, beats/min 66.8  	 10.2 63.5  	 10.9 ‡ 67.3  	 10.1 64.8  	 11.9 ∗ 
Central haemodynamics
 Systolic pressure, mmHg 110.2  	 18.0 113.7  	 15.4 ‡ 107.9  	 18.1 109.8  	 13.3
 Diastolic pressure, mmHg 76.1  	 10.4 79.8  	 10.7‡ 74.8  	 9.8 77.8  	 10.4 † 
 Pulse pressure, mmHg 34.0  	 12.3 33.9  	 10.2 33.1  	 12.6 32.0  	 8.9
 Values are mean  	 SD or numbers of subjects (%).  – , missing information; CVD, cardiovascular disease. Hypertension was a blood pressure 
of at least 140 mmHg systolic or 90 mmHg diastolic. Signifi cance of the sex difference  ∗ p   0.05,  † p   0.01,  ‡ p   0.001. 
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(Figure 2, Panels C and D and Table II;  p -value for 
sex difference, 0.50). 
 Systolic augmentation pressure, the difference 
between maximal and non-augmented systolic 
pressure, increased with age, but the slope was smaller 
( p   0.0001) for the peripheral than for the central 
augmentation pressure: 0.050 vs 0.395 mmHg/year in 
women and 0.019 vs 0.301 mmHg/year in men. The 
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Figure 2. Association with age of peripheral and central systolic blood pressures (A, B), peripheral and central non-augmented systolic 
blood pressures (A, B), pressure amplifi cation (C, D), and peripheral and central systolic augmentation (E, F) in women (A, C, E) and 
men (B, D, F). Peripheral systolic blood pressure was the average of three blood pressure readings at the brachial artery. Central systolic 
blood pressure was the maximum pressure of the central waveform. Systolic augmentation was obtained by subtracting the fi rst systolic 
peak from systolic blood pressure. Pressure amplifi cation is peripheral minus central systolic blood pressure. Plotted values are means for 
each age group. Numbers indicate the subjects contributing to the group means. All p-values for trend with age were statistically signifi cant 
(p  0.0001). Signifi cance of the difference with zero: ∗p  0.05, †p  0.001.
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slopes of peripheral and central systolic augmenta-
tion pressure were steeper ( p   0.001) in women 
than in men. In women (  20 vs 40 – 50 years) as 
well as in men (30 – 40 vs 60 – 70 years), central sys-
tolic augmentation occurred at a younger age than 
peripheral systolic augmentation (Figure 2; Panels 
E and F). 
 The cross-sectional fi ndings in the subsample of 
208 women and 190 men were generally consistent 
with those in the overall study population (Table II 
and Figure 3). The slopes on age of the peripheral 
and central systolic blood pressures and the amplifi -
cation pressure were similar at baseline and follow-up 
( P   0.17). However, in the subsample, the cross-
sectionally assessed increase in the peripheral and 
central systolic augmentation pressures with age 
appeared to be smaller at baseline than at follow-up 
( P   0.01). 
 In the longitudinal analyses, all changes from 
baseline to follow-up were signifi cant ( P   0.039) 
except for the peripheral systolic augmentation in 
men ( p   0.09). The annual increases in the peri-
pheral and central systolic blood pressures aver-
aged 0.91 mmHg and 1.06 mmHg in women, and 
1.24 mmHg and 1.47 mmHg in men (Table II and 
Figure 3). The  p -values for the sex differences were 
0.12 and 0.08, respectively. In the longitudinal 
analyses, women had more pressure amplifi cation 
than men (  0.27 vs   0.23 mmHg/year;  p   0.001; 
Table II). The annual changes in the peripheral 
and central systolic augmentation pressures were 
0.10 mmHg and 0.55 mmHg in women, and 0.02 
mmHg and 0.51 mmHg in men. Longitudinally, 
the central systolic augmentation was similar in 
both sexes ( p   0.64), whereas the peripheral sys-
tolic augmentation was larger in women than in 
men ( p   0.002). 
 To evaluate to what extent regression-to-the-
mean might infl uence the longitudinal changes in 
systolic blood pressure, we assessed these changes by 
quarters of the brachial (peripheral) systolic blood 
pressure at baseline (Table III). For peripheral, but 
not central systolic blood pressure, the increase over 
time weakened across the quarters in women. In 
men, the increases over time in both peripheral and 
central systolic blood pressure weakened across the 
quarters of baseline peripheral systolic blood pres-
sure. In men, pressure amplifi cation decline tended 
( p   0.041) to increase with higher peripheral systolic 
blood pressure at baseline Table III). 
 Multivariable analyses 
 Table IV summarizes the results of stepwise regres-
sion in the cross-sectional analysis with peripheral 
and central systolic blood pressures as the dependent 
variables. Age contributed most of the explained 
variance. The multivariable-adjusted slopes of blood 
pressure on age were of similar magnitude as those 
in single regression analysis (Table II). In both 
women and men, the peripheral and central systolic 
blood pressures increased with body mass index and 
heart rate. The slopes of central blood pressure on 
age were signifi cantly steeper than those of the 
peripheral systolic blood pressure. In women, the 
peripheral and central systolic blood pressure tended 
Table II. Cross-sectional association of blood pressure with age and longitudinal change in blood pressure with ageing in women and men.
Cross-sectional associations with age (mmHg/year)
Longitudinal change (mmHg/year)
Follow-up minus baselineVariables by sex Timing Baseline Baseline Follow-up
Women All Subgroup Subgroup Subgroup
 Number 731 208 208 208
 Peripheral systolic pressure 0.48 	 0.03 0.48 	 0.06 0.58 	 0.07 0.91 	 0.19
 Central systolic pressure 0.73 	 0.03 0.72 	 0.06 0.79 	 0.06 1.06 	 0.22
 Pressure amplifi cation   0.24 	 0.01   0.23 	 0.02   0.22 	 0.02  0.27 	 0.07
 Peripheral systolic augmentation 0.0500 	 0.0059 0.0455 	 0.0084 0.0955 	 0.0154∗ 0.1010 	 0.0267
 Central systolic augmentation 0.395 	 0.013 0.399 	 0.023 0.472 	 0.026∗ 0.551 	 0.073
Men
 Number 689 190 190 190
 Peripheral systolic pressure 0.27 	 0.03 0.14 	 0.05 0.21 	 0.06 1.24 	 0.21
 Central systolic pressure 0.51 	 0.03 0.40 	 0.05 0.49 	 0.06 1.47 	 0.20
 Pressure amplifi cation   0.24 	 0.01   0.26 	 0.02   0.29 	 0.02   0.23 	 0.09
 Peripheral systolic augmentation 0.0187 	 0.0039 0.0006 	 0.0002 0.0167 	 0.0046∗ 0.0220 	 0.0104
 Central systolic augmentation 0.301 	 0.012 0.278 	 0.019 0.330 	 0.023∗ 0.513 	 0.074
Regression coeffi cients (β 	 SE) describe the cross-sectional associations of blood pressure with age. Subgroup refers to the subjects with 
repeat haemodynamic measurements at a median interval of 4.79 years. For the longitudinal assessment, values are average changes per 
year (follow-up minus baseline). Peripheral systolic blood pressure was the average of three blood pressure readings at the brachial artery. 
Central systolic blood pressure was the maximum pressure of the central waveform. Systolic augmentation was obtained by subtracting 
the fi rst systolic peak from systolic blood pressure. Pressure amplifi cation is peripheral minus central systolic blood pressure. All slopes 
on age were statistically signifi cant (p  0.01). In subjects with repeat examinations, an asterisk indicates a signifi cant difference (p  0.039) 
between baseline and follow-up in the cross-sectionally assessed slopes on age. All changes from baseline to follow-up were signifi cant 
(p  0.05) except for peripheral systolic augmentation in men (p  0.09).
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to be 2.81 and 2.31 mmHg lower in smokers than 
non-smokers ( P   0.08). 
 In the whole study group, pressure amplifi  -
cation signifi cantly and independently decreased 
with age (partial regression coeffi cient  	 SE, 
  0.22  	 0.01 mmHg/year;  p   0.0001), female sex 
( – 4.08  	 0.24 mmHg;  p   0.0001) and current smok-
ing (  0.86  	 0.29 mmHg;  p   0.003), whereas it 
increased with heart rate (0.13  	 0.01 mmHg/heart 
beat;  p   0.0001). 
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Figure 3. Blood pressures at baseline and follow-up by sex and quarters of the age distribution. Plotted values are peripheral and central 
systolic blood pressures (A, B), pressure amplifi cation (C, D), and peripheral and central systolic augmentation (E, F) in 208 women (A, 
C, E) and 190 men (B, D, F). All p-values for trend with age were statistically signifi cant (p  0.01). Signifi cance of the difference between 
baseline and follow-up: ∗p  0.05, †p  0.01, ‡p  0.001.
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 Discussion 
 The present reports focused on the changes with age 
in systolic augmentation of the central and peripheral 
systolic blood pressures in randomly recruited 
white Caucasians. In the cross-sectional analysis, the 
age-related increase was steeper for the central than 
for the peripheral systolic blood pressure. Systolic 
augmentation, defi ned as systolic blood pressure minus 
the fi rst systolic peak, increased with age, but the 
increase was considerably larger for the central than 
for the peripheral systolic blood pressure. The ampli-
fi cation of systolic blood pressure, the difference 
between the peripheral systolic and central pressure 
therefore decreased with age. 
Table IV. Correlates of peripheral and central systolic blood pressures in women and men.
Women (n  731) Men (n  689)
Peripheral Central p Peripheral Central p
R2 0.28 0.40 0.14 0.29
Intercept 69.4 57.1 95.9 72.5
Age (years)
 β 	 SE 0.421 	 0.038§ 0.651 	 0.039§  0.0001 0.236 	 0.037§ 0.464 	 0.035§  0.0001
 Partial r2 0.198 0.359 0.076 0.261
Body mass index, kg/m2
 β 	 SE 0.830 	 0.120§ 0.815 	 0.122§ 0.546 0.486 	 0.146‡ 0.499 	 0.137§ 0.474
 Partial r2 0.062 0.043 0.014 0.017
Heart rate, beats/min
 β 	 SE 0.202 	 0.051† 0.094 	 0.053∗ 0.172 0.287 	 0.049‡ 0.136 	 0.046‡ 0.109
 Partial r2 0.016 0.003 0.052 0.009
Smoking (0,1)
 β 	 SE –2.811 	 1.308† –2.311 	 1.334∗ 0.182 ns ns –
 Partial r2 0.005 0.002
Values are partial regression coeffi cients (β 	 SE) or partial coeffi cients of determination (r2). Signifi cance of the partial regression 
coeffi cient: ns p  0.10; ∗p  0.10; †p  0.05, ‡p  0.01, §p  0.001. The covariables considered in the stepwise regression procedure were: 
age, body mass index, heart rate and current smoking and drinking. p-values are for the comparison of the partial regression coeffi cients 
describing the associations with peripheral vs central blood pressure. –, not applicable.
Table III. Longitudinal changes in blood pressure by quarters of the distribution of peripheral systolic blood pressure at baseline in women 
and men.
Quarters of the distribution of peripheral systolic blood pressure at baseline
Characteristic Low Medium-low Medium-high High p-value
Women
 Range of SBP at baseline, mmHg   108 108–116 117–126 127
 Number of subjects 50 52 54 52
 Peripheral SBP
  Baseline, mmHg 101.3 	 4.1 111.1 	 2.2 118.8 	 2.3 138.0 	 12.9   0.0001
  Follow-up, mmHg 109.7 	 10.5 117.4 	 10.1 121.5 	 11.3 137.5 	 17.4   0.0001
  Absolute change, mmHg/year 1.73 	 2.36‡ 1.33 	 2.08‡ 0.82 	 2.45∗ 0.13 	 3.51 0.0028
 Central SBP
  Baseline, mmHg 90.2 	 17.4 100.8 	 5.4 108.2 	 7.2 128.2 	 13.7   0.0001
  Follow-up, mmHg 100.5 	 10.1 108.1 	 11.5 113.2 	 12.6 129.3 	 18.6   0.0001
  Absolute change, mmHg/year 1.59 	 3.92† 1.50 	 2.19‡ 1.08 	 2.59† 0.18 	 3.50 0.076
 Pressure amplifi cation, mmHg/year  0.34 	 1.16∗   0.17 	 1.04  0.26 	 0.76∗ 0.31 	 0.81† 0.50
Men
 Range of SBP at baseline, mmHg  117 117–124 125–132 133
 Number of subjects 45 49 48 48
 Peripheral SBP
  Baseline, mmHg 110.6 	 5.4 119.7 	 1.5 127.2 	 2.28 141.1 	 9.6   0.0001
  Follow-up, mmHg 122.8 	 13.6 125.8 	 9.2 130.7 	 12.1 143.7 	 15.2   0.0001
  Absolute change, mmHg/year 2.46 	 3.12‡ 1.29 	 1.97‡ 0.70 	 2.65 0.49 	 3.40 0.0043
 Central SBP
  Baseline, mmHg 97.5 	 6.5 105.5 	 5.6 112.2 	 7.5 124.4 	 13.7   0.0001
  Follow-up, mmHg 109.9 	 12.8 112.8 	 10.8 117.0 	 13.0 128.6 	 17.4   0.0001
  Absolute change, mmHg/year 2.48 	 2.74‡ 1.56 	 1.85‡ 0.98 	 2.56∗ 0.85 	 3.54 0.017
 Pressure amplifi cation, mmHg/year  0.02 	 1.46   0.26 	 0.98   0.28 	 1.35 0.36 	 1.16∗ 0.041
Values are arithmetic means 	 SD. SBP, systolic blood pressure. All changes from baseline to follow-up were signifi cant (p  0.05). Change 
in blood pressure was computed by subtracting baseline from follow-up measurements. p-values are for trend across quarters. Signifi cance 
of the within-group changes: ∗p  0.05, †p  0.01, ‡p  0.001.
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 Our cross-sectional observations are in agree-
ment with known physiological concepts, initially 
tested in experimental studies (14) and in selected 
patients (14 – 16). They are also in line with several 
previously published cross-sectional population stud-
ies (17 – 19), including the Anglo-Cardiff Collabora-
tive Trial (ACCT) (17). McEniery and colleagues 
(17) studied 4001 healthy, normotensive individuals, 
aged 18 – 90 years. In both women and men, central 
systolic pressure increased more with age than did 
peripheral systolic blood pressure ( p   0.001). As in 
our current cross-sectional analyses, the increase in 
central systolic pressure was more prominent in women 
than men ( p   0.01). Wilkinson and coworkers (18) 
combined volunteers recruited from the community 
and patients attending an open access clinic for the 
assessment of cardiovascular risk. They excluded 
patients with a cardiovascular disease, diabetes or on 
drug treatment, but not those with hypertension. 
Pressure amplifi cation, defi ned as the peripheral-to-
central pulse pressure ratio decreased linearly with 
age ( r     0.7;  p   0.001). However, the relation with 
age of the ratio of peripheral pulse pressure to the 
non-augmented central pulse pressure was not sta-
tistically signifi cant ( r   0.1;  p   0.1). 
 In a cross-sectional analysis (19), Mitchell and 
coworkers measured proximal aortic pressure and 
fl ow, forward pressure wave amplitude, global wave 
refl ection, refl ected wave timing, and pulse wave 
velocity non-invasively in 6417 participants of the 
Framingham Heart Study (age range 19 – 90 years; 
53% women). Across the age range, the forward 
wave amplitude explained most of the variance of 
central (89%) and peripheral (84%) pulse pres-
sures. Below 50 years of age, the central and periph-
eral pulse pressures decreased with age, but refl ected 
waves increased with advancing age, whereas the 
opposite occurred above age 50 years. The forward 
wave amplitude explained 80% (central) and 66% 
(peripheral) of the variance in pulse pressure in 
younger participants (  50 years) and 90% and 
84% in the older participants (  50 years; all 
 p   0.0001) (19). 
 A recent publication of the ACCT (20) involved 
healthy people, subjects with risk factors, such as 
hypertension, hypercholesterolaemia, smoking, dia-
betes, diabetic patients and patients with a history of 
cardiovascular disease. The 10,613 participants were 
18 – 101 years old (50.8% women). In this report, 
McEniery and colleagues chose to express aortic 
pulse pressure relative to brachial pulse pressure, i.e. 
the reciprocal of the traditionally used pressure 
amplifi cation. Higher values of this new index repre-
sent subjects with a relatively higher aortic pressure 
for a given brachial pressure. The aorta-to-brachial 
pulse pressure ratio averaged 0.72 in healthy subjects 
and was consistently and signifi cantly higher in all 
other groups (range of means 0.77 – 0.80) with the 
exception of smokers (mean value   0.66). 
 In our current study, peripheral and central 
systolic blood pressures were lower in smoking than 
non-smoking women. Smoking acutely raises blood 
pressure through sympathetic stimulation (21), and 
is associated with higher blood pressure, at least if 
the latter is continuously recorded (22). In contrast, 
in epidemiological studies in which the conventional 
blood pressure was measured after a smoking-free 
interval, smokers show slightly lower blood pressure 
levels than non-smokers (23). This may be related to 
the reduction in sympathetic activity in the intervals 
between smoking (24), the development of tolerance 
(25) or to the lower body weight of smokers. In McE-
niery ’ s report, ageing was associated with an increased 
aorta-to-brachial pulse pressure ratio. Above 80 
years, the difference between peripheral and central 
systolic blood pressure still averaged 8 mmHg in 
women and 11 mmHg in men. In our current study, 
the corresponding values were 6.0 mmHg ( n   22) 
and 10.4 mmHg ( n   28), respectively. 
 To our knowledge, our current study is among 
the fi rst to examine pressure amplifi cation in a lon-
gitudinal manner. The age-related increases in 
peripheral and central systolic blood pressures were 
consistently greater on longitudinal compared with 
the cross-sectional assessment. Because of the strin-
gent quality control programme set up for the blood 
pressure measurements (6), it is unlikely that drift in 
methodology can explain these observations. Cal-
culating a difference between repeated measurements 
in the same individual might not be equivalent to 
computing a correlation coeffi cient across different 
subjects. As shown in Table III, longitudinal data are 
sensitive to regression-to-the-mean. Furthermore, 
systolic blood pressure is a major risk factor. Subjects 
at the higher end of the distribution of systolic blood 
pressure are more likely to experience cardiovascular 
complications or die, and therefore to disappear from 
follow-up. The unmeasured attrition in the popu-
lation available for cross-sectional analysis might at 
least contribute to the larger estimates of the age-
related increase in the longitudinal assessment. 
Women have a longer life expectancy than men. 
Stronger attrition among men might explain why in 
the longitudinal analysis pressure amplifi cation 
decreased more over time in women than men 
(  0.27 vs   0.23 mmHg/year), whereas in the cross-
sectional analysis there was no sex difference (  0.24 
vs   0.24 mmHg/year). Because central systolic blood 
pressure is a predictor of cardiovascular complica-
tions (26 – 30), the latter assumptions need to be 
ascertained in other prospective population studies. 
 The present study should be interpreted within the 
context of its potential limitations. First, in contrast to 
other studies on the age dependency of arterial stiff-
ness (17,18,31,32), we did not exclude patients with 
hypertension, diabetes or previous cardiovascular dis-
ease. On the other hand, we excluded patients on anti-
hypertensive drug treatment. Second, in our current 
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study, as in all other cross-sectional studies, age was 
the overriding determinant of the peripheral and cen-
tral systolic blood pressures with smaller contributions 
of sex, body mass index, heart rate and smoking. Our 
sample size might have been insuffi cient to identify 
other blood pressure correlates, such as alcohol intake, 
serum total cholesterol or blood glucose. Finally we 
did not assess the pulse wave contour at the brachial 
artery and we could therefore not account for any 
brachial-to-radial amplifi cation, which as estimated 
non-invasively but not invasively contributes to total 
amplifi cation and increase with age (33,34). However, 
brachial tonometry is technically demanding (34,35). 
In experienced hands, it is successful in less than 80% 
of individuals (35). 
 Our current fi ndings set an agenda for research. 
Indeed, they are based on white  Caucasian popula-
tions with a western life style, high prevalence of 
obesity and relatively high cholesterol levels. They 
cannot be extrapolated to other ethnicities or popula-
tions with different lifestyles. It would be of great 
interest to explore whether our current fi ndings can 
be replicated in lean Asian people, who generally 
have lower serum cholesterol levels. The hypothesis 
of an underestimation of the association between sys-
tolic blood pressure and age in cross-sectional stud-
ies needs clarifi cation. Finally, the currently available 
literature on the amplifi cation of systolic blood pres-
sure is diffi cult to interpret, because varying defi ni-
tions are being used (19,20). Experts committees 
might wish to provide guidance in standardizing the 
terminology. 
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